Cargando...
Biomarkers in the Assessment of Therapies for Familial Amyloidotic Polyneuropathy
The identification of specific biomarkers provides opportunities to develop early diagnostic parameters, monitor disease progression, and test drug efficiency in clinical trials. We previously demonstrated that in familial amyloidotic polyneuropathy (FAP) related to the abnormal extracellular tissue...
Gardado en:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
ScholarOne
2007
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2017105/ https://ncbi.nlm.nih.gov/pubmed/17932549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/2007-00068.Macedo |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|